Where Things Stand with Roundup Litigation

Bayer AG, which acquired Monsanto in 2018 along with its massive glyphosate liability, has been working for years to resolve tens of thousands of Roundup cancer lawsuits. Despite reaching a landmark $10.9 billion settlement agreement in 2020, the litigation has proven far more durable than the company anticipated.

As of early 2025, Bayer continues to face an active inventory of claims — including cases filed by plaintiffs who opted out of prior settlement pools and new cases added each month by individuals diagnosed with non-Hodgkin's lymphoma after years of Roundup use.

What Bayer's Current Strategy Looks Like

Bayer has publicly stated its intention to pursue a "science-based" resolution at the U.S. Supreme Court level, arguing that federal pesticide law pre-empts state-level failure-to-warn claims. The company has repeatedly sought certiorari on this question, and legal observers are watching closely to see whether the Supreme Court agrees to hear the case.

"The key legal question is whether EPA's approval of glyphosate's label effectively shields Bayer from state tort claims — an argument courts have so far largely rejected."

At the trial level, Bayer has had mixed results. Several high-profile verdicts against the company have been upheld on appeal, while others have been remanded or reduced. The company has set aside substantial reserves for ongoing claims but has also indicated it is not willing to settle indefinitely.

What This Means for Pending Claimants

If you have a pending Roundup claim — or believe you may have one — the evolving settlement landscape has several practical implications:

  • Statute of limitations: State filing deadlines vary from one to three years from diagnosis or discovery of the link between your cancer and Roundup exposure. Do not wait.
  • Evidence preservation: Purchase receipts, photographs, medical records, and employer documentation of Roundup use all strengthen your claim. Gather these now.
  • Settlement timing: The overall resolution of Roundup litigation may take years more. Individual settlements are still occurring, but the terms and timelines depend heavily on the specific facts of each claim.
  • New plaintiffs still accepted: If you have been diagnosed with non-Hodgkin's lymphoma, leukemia, or another cancer linked to glyphosate exposure, it is not too late to explore a claim.

Linked Cancers and Qualifying Exposure

The strongest evidence in Roundup litigation centers on non-Hodgkin's lymphoma (NHL), which has been the basis for the largest verdicts. Researchers have also studied links to B-cell lymphoma, T-cell lymphoma, and certain forms of leukemia.

Qualifying exposure typically means regular, repeated contact with Roundup or other glyphosate-containing products — whether as a homeowner, agricultural worker, landscaper, or groundskeeper. Occupational exposure cases tend to be stronger due to the frequency and volume of contact involved.

Case Alert: If you or a family member was diagnosed with non-Hodgkin's lymphoma and regularly used Roundup or a glyphosate-based herbicide, contact Triten Law today for a free, confidential evaluation. Time limits apply.

The Bottom Line

Bayer's Roundup litigation is one of the largest ongoing mass tort disputes in American legal history. While the ultimate resolution remains uncertain, courts have consistently sided with plaintiffs on the core question of Monsanto's failure to warn — and recoveries remain very much available for qualified claimants.

← Back to News & Insights